Demcizumab
Product Specifications
CAS Number
1243262-17-0
Target
Gamma-secretase
Related Pathways
Proteases/Proteasome, Stem Cells, Neuroscience
Purity
>95%
Bioactivity
Demcizumab (OMP 21M18) is an anti-DLL4 monoclonal antibody and a potent Notch pathway inhibitor, demonstrating efficacy in various cancer models both as a monotherapy and in conjunction with chemotherapy agents.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1358990-01 0.02 mg (E-Coli)
Recombinant Vibrio vulnificus Adenylyl-sulfate kinase (cysC)
Sign In for Pricing
View Details MBS1358990-02 0.1 mg (E-Coli)
Recombinant Vibrio vulnificus Adenylyl-sulfate kinase (cysC)
Sign In for Pricing
View Details MBS1358990-03 0.02 mg (Yeast)
Recombinant Vibrio vulnificus Adenylyl-sulfate kinase (cysC)
Sign In for Pricing
View Details MBS1358990-04 0.1 mg (Yeast)
Recombinant Vibrio vulnificus Adenylyl-sulfate kinase (cysC)
Sign In for Pricing
View Details MBS1358990-05 0.02 mg (Baculovirus)
Recombinant Vibrio vulnificus Adenylyl-sulfate kinase (cysC)
Sign In for Pricing
View Details MBS1358990-06 0.02 mg (Mammalian-Cell)
Recombinant Vibrio vulnificus Adenylyl-sulfate kinase (cysC)
Sign In for Pricing
View Details